(THER) Antiarrhythmic Agents I and II Flashcards
What is the difference between pacemaker cells and regular myocytes?
They lack fast Na+ channels and as such their refractory period is determined by time, via a slow inward Na+ current (If = funny channels)
ALL arrhythmias result from what (3) things?
- Disturbed impulse formation
- Disturbed impulse conduction
- Combination of 1 and 2
General symptoms from cardiac arrhythmias
Wide range from asymptomatic to severe hemodynamic consequences with reduced CO and death.
Types of Cardiac Arrhythmias (3)
- Too slow (bradycardia/bradyarrhythmia)
- Too fast (tachycardia/tachyarrhythmia)
- Asynchronous
In general, the aim of anti-arrhythmic therapy is to reduce…
Ectopic pacemaker activity and/or modify conduction characteristics to restore normal function.
What is one of the most dangerous potential side effects of anti-arrhythmic drugs?
The development of lethal arrhythmias because these drugs do not act specifically.
Depends on dosage or physciological conditions, such as faster heart rate, acidosis, electrolytes or presence of ischemia.
Are early afterdepolarizations usually at slow or fast heart rates? DAD’s?
EAD: slow
DAD: fast
What are the (3) requirements for reentry?
- Block (SA/AV block)
- Unidirectional conduction
- Slowed conduction through block
What are the (4) ways to regulate rate of pacemaker cells with abnormal automaticity?
- Reduction of phase 4 slope
- Increase of max Em
- Increase of threshold potential
- Increase of action potential duration
How might a drug that affects the recovery time Na+ or Ca2+ channels effect arrhythmias?
Tachy-arrhythmias and premature beats (short cycle lengths) depend on the ability of Na+ channels to activate, inactivate and recover from inactivation RAPIDLY.
If a drug prolongs the recovery time of the Na+ channel (or Ca++ channel), then it may prevent re-entry, block tachycardias and prevent premature beats from occurring.
Describe the functioning of use-dependent or state-dependent drug action
They selectively block depolarized cells
They suppress channels that are used/inactivated frequently are more suceptible e.g. during fast tachy (when many channels are activated/inactivated) or in ischemic or infarcted tissues (more positive RMP).
Normal cells rapidly lose the drug during the resting phase
What drug is best for treatment of asymptomatic or minimally symptomatic arrhythmias?
TREATMENT SHOULD BE AVOIDED!
This is due to the potential of anti-arrhythmics to cause lethal arrhythmias
Name the Vaughan Williams Classification of Anti-Arrhythmic Drug Actions
Class I: Na+ channel blockers
Class II: B-adrenoceptor blockers
Class III: prolongation of the AP duration
Class IV: Ca2+ channel blockers
Other
Describe Class I Anti-Arrhythmics
What are they? What does their action depend on?
Na+ channel blockers (local anesthetic action)
Block fast Na+ channels. Actions depend on HR, Em and drug specific blocking kinetics
How do Na+ channel Blockers (Class I anti-arrhythmics) influence depolarization? repolarization?
Depolarization influence via: reduction of conduction velocity by reducing rate and magnitude of depolarization
Repolarization influence via: effects on K+ channels which may proong the AP duration
What are the (3) subclasses under type I anti-arrhythmics and which drugs full under which categories?
Class IA: intermediate kinetics, increases action potential duration (APD)
Drugs: Procainamide, Quinidine and Disopyramide
Class IB: Fast kinetics, decreases APD
Drugs: Lidocaine, mexiletine
Class IC: slow kinetics, no effect on APD
Drugs: Flecainide, Propafenone
Procainamide MOA and Effects
(what does it block? via what type of action? what is the electrical effect of its action? how does this effect rate?)
Blocks Na+ and K+ channels via use/state dependent action
This slows upstroke of AP and conduction, prolonging the QRS.
This has direct depressant actions on SA/AV nodes
Procainamide Indications
(also, what choice drug is it?)
Atrial and ventricular arrhythmias
2nd choice for vent. arrhythmias after acute MI
Procainamide route/half-life/ elimination
Route: PO/IV
t1/2: 3-4 hrs
elim: renal
Procainamide AEs (4)
- Torsades des pointes
- Hypotension
- Anticholinergic effects
- Lupus syndrome (long term use)
Quinidine is similar to what drug?
Procainamide
How does quinidine differ from procainamide?
- stronger anticholinergic effects
- cinchonism (headache, dizzines, tinnitus)
- it is rarely used because of cardiac/extra-cardiac AEs
Disopyramide is similar to what other drug?
Procainamide
How is disopyramide different from procainamide? (2)
- Much greater anticholinergic effects than procainamide and quinidine
- Negative inotropic effects which may induce heart failure
Because of the anti-cholinergic effects of disopyramide, it requires co-administration of drugs that…
slow AV conduction
What is the only inducation that disopyramide is approved for?
It is a 1st or 2nd choice drug for ventricular arrhythmias
Lidocaine MOA/effects
(What does it do? What kind of drug action?)
Na+ channel blockade.
Use/state-dependent drug action
Lidocaine Indications
What is it not recommended for?
- Ventricular arrhythmias after MI
- 1st choice for V. tach/V. fib after cardioversion in setting of ischemia/infarction
Not recommended for prophylactic treatment (may increase mortality)
Lidocaine route/ metabolization/ t 1/2
Route: IV only
Metabolism: Extensive 1st pass metabolism
t1/2: 1-2 hours
Lidocaine AEs
Least cardiotoxic drug among Class I drugs
Neurological side ffects due to local anesthetic properties.
What is Mexiletine?
An oral lidocaine analogue. Actions/AEs are similar to lidocaine.
How is Mexiletine different from lidocaine?
(half-life? Other uses?)
t 1/2: 8-20 hours
Off-label use: chronic pain (diabetic neuropathy/nerve injury)
Flecainamide MOA
Na+ and K+ blockade
How does flecainamide affect AP duration and cholinergic effects?
Although K+ channel blocker, no effects on AP duration or anticholinergic effects
Flecainamide indications
Indication: supraventricular arrhythmias in patients with otherwise normal hearts
Flecainamide AEs
Increases mortality in patients with v. tach, MI, and ventricular ectopy (ALL CONTRAINDICATED)